Ranson’s Criteria

What is Ranson’s criteria?

Ranson’s criteria are a clinical prediction tool used to estimate severity and mortality risk in acute pancreatitis. It uses clinical and laboratory variables assessed at admission and again at 48 hours to estimate the likelihood of severe disease. Severe disease manifests in approximately 20% of cases, where multiorgan failure serves as the primary cause of early mortality. The full Ranson score is completed 48 hours after admission, which limits its utility for very early risk stratification. This scoring system aids in flagging high-risk individuals before significant decompensation occurs.

How are Ranson’s criteria structured?

The classic Ranson criteria uses 11 distinct parameters divided into two assessment phases. Five variables are measured upon hospital admission. These include age over 55, white cell count exceeding 16,000/µL, blood glucose exceeding 200 mg/dL, LDH exceeding 350 IU/L, and AST exceeding 250 IU/L.

Six additional variables are reassessed at the 48-hour mark to monitor disease progression and the response to initial therapy. This 48-hour panel includes a hematocrit drop of more than 10% and a BUN increase of more than 5 mg/dL despite IV fluid hydration. It also tracks serum calcium levels below 8 mg/dL, a PaO2 less than 60 mmHg, a base deficit greater than 4 mEq/L, and fluid sequestration exceeding 6 L. These markers collectively reflect the degree of systemic inflammatory response and third-space fluid loss. There is a modified version of the Ranson score for gallstone pancreatitis, which uses different thresholds and 10 total parameters.

How is Ranson’s criteria used in clinical assessment?

Clinicians use the Ranson score as one adjunct for estimating severity in acute pancreatitis. A score of 3 or more suggests severe acute pancreatitis and increased risk of complications and mortality, while a score below 3 makes severe disease less likely. Also known as pancreatitis criteria, the full score is not available until 48 hours, and should complement rather than drive immediate triage decisions. In current practice, the score is best interpreted alongside the overall clinical picture and modern severity classifications rather than as a standalone trigger for specific interventions.

What are the limitations of Ranson’s criteria?

While historically valuable, Ranson’s criteria have specific limitations in modern clinical settings. A key limitation is that the classic score applies to non-gallstone pancreatitis, because the original cohort primarily consisted of individuals with alcoholic pancreatitis. Thus, gallstone pancreatitis uses modified Ranson criteria with different thresholds. Furthermore, the requirement for a 48-hour waiting period to complete the score can delay definitive risk stratification in rapidly progressing cases.

Recent evidence compares these metrics with newer tools such as APACHE II and BISAP. Its main limitations are the 48-hour delay, the number of variables, and the need for different thresholds in gallstone pancreatitis. BISAP or APACHE II may be more practical when earlier or repeated assessment is needed.

What are the most important facts to know about the Ranson’s criteria?

• Ranson’s criteria predict mortality in patients with acute pancreatitis by evaluating physiologic markers at admission and again at 48 hours.
• Admission markers include age, white cell count, glucose, LDH, and AST, while the 48-hour reassessment monitors fluid shifts and oxygenation.
• A Ranson score of 3 or greater suggests severe disease, typically needing aggressive fluid resuscitation and possible ICU-level care.
• Ranson’s criteria remain historically important, but newer scores like APACHE II or BISAP are often used when earlier or repeated severity assessment is needed.